179 related articles for article (PubMed ID: 37076317)
1. New advances in menopause symptom management.
Koysombat K; McGown P; Nyunt S; Abbara A; Dhillo WS
Best Pract Res Clin Endocrinol Metab; 2024 Jan; 38(1):101774. PubMed ID: 37076317
[TBL] [Abstract][Full Text] [Related]
2. Neurokinin 3 Receptor Antagonism: A Novel Treatment for Menopausal Hot Flushes.
Modi M; Dhillo WS
Neuroendocrinology; 2019; 109(3):242-248. PubMed ID: 30504731
[TBL] [Abstract][Full Text] [Related]
3. Neurokinin B and Neurokinin-3 Receptor Signaling: Promising Developments in the Management of Menopausal Hot Flushes.
Modi M; Dhillo WS
Semin Reprod Med; 2019 May; 37(3):125-130. PubMed ID: 31869840
[TBL] [Abstract][Full Text] [Related]
4. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
[TBL] [Abstract][Full Text] [Related]
5. Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.
Tahara A; Takamatsu H; Ohtake A; Tanaka-Amino K; Kaku S
Eur J Pharmacol; 2021 Aug; 905():174207. PubMed ID: 34048742
[TBL] [Abstract][Full Text] [Related]
6. The role of kisspeptin/neurokinin B/dynorphin neurons in pathomechanism of vasomotor symptoms in postmenopausal women: from physiology to potential therapeutic applications.
Szeliga A; Czyzyk A; Podfigurna A; Genazzani AR; Genazzani AD; Meczekalski B
Gynecol Endocrinol; 2018 Nov; 34(11):913-919. PubMed ID: 29902942
[TBL] [Abstract][Full Text] [Related]
7. The neurokinin B pathway in the treatment of menopausal hot flushes.
Anderson RA; Skorupskaite K; Sassarini J
Climacteric; 2019 Feb; 22(1):51-54. PubMed ID: 30572747
[TBL] [Abstract][Full Text] [Related]
8. Menopause review: Emerging treatments for menopausal symptoms.
Patel B; S Dhillo W
Best Pract Res Clin Obstet Gynaecol; 2022 May; 81():134-144. PubMed ID: 34965909
[TBL] [Abstract][Full Text] [Related]
9. Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.
Prague JK; Roberts RE; Comninos AN; Clarke S; Jayasena CN; Nash Z; Doyle C; Papadopoulou DA; Bloom SR; Mohideen P; Panay N; Hunter MS; Veldhuis JD; Webber LC; Huson L; Dhillo WS
Lancet; 2017 May; 389(10081):1809-1820. PubMed ID: 28385352
[TBL] [Abstract][Full Text] [Related]
10. Activation of neurokinin 3 receptors in the median preoptic nucleus decreases core temperature in the rat.
Dacks PA; Krajewski SJ; Rance NE
Endocrinology; 2011 Dec; 152(12):4894-905. PubMed ID: 22028440
[TBL] [Abstract][Full Text] [Related]
11. The neuroendocrinology of the preoptic area in menopause: Symptoms and therapeutic strategies.
Modi M; Dhillo WS
Handb Clin Neurol; 2021; 179():455-460. PubMed ID: 34225982
[TBL] [Abstract][Full Text] [Related]
12. Neurokinin 3 receptor antagonists - prime time?
Prague JK
Climacteric; 2021 Feb; 24(1):25-31. PubMed ID: 33135940
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin 3 receptor antagonism - the magic bullet for hot flushes?
Prague JK; Dhillo WS
Climacteric; 2017 Dec; 20(6):505-509. PubMed ID: 29040006
[TBL] [Abstract][Full Text] [Related]
14. What causes hot flushes? The neuroendocrine origin of vasomotor symptoms in the menopause.
Rossmanith WG; Ruebberdt W
Gynecol Endocrinol; 2009 May; 25(5):303-14. PubMed ID: 19903037
[TBL] [Abstract][Full Text] [Related]
15. Neurokinin B administration induces hot flushes in women.
Jayasena CN; Comninos AN; Stefanopoulou E; Buckley A; Narayanaswamy S; Izzi-Engbeaya C; Abbara A; Ratnasabapathy R; Mogford J; Ng N; Sarang Z; Ghatei MA; Bloom SR; Hunter MS; Dhillo WS
Sci Rep; 2015 Feb; 5():8466. PubMed ID: 25683060
[TBL] [Abstract][Full Text] [Related]
16. Menopausal hot flushes and night sweats: where are we now?
Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
[TBL] [Abstract][Full Text] [Related]
17. Fezolinetant in the treatment of vasomotor symptoms associated with menopause.
Depypere H; Lademacher C; Siddiqui E; Fraser GL
Expert Opin Investig Drugs; 2021 Jul; 30(7):681-694. PubMed ID: 33724119
[No Abstract] [Full Text] [Related]
18. Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: a comprehensive review.
Utian WH
Health Qual Life Outcomes; 2005 Aug; 3():47. PubMed ID: 16083502
[TBL] [Abstract][Full Text] [Related]
19. Assessment and treatment of hot flushes and menopausal mood disturbance.
Joffe H; Soares CN; Cohen LS
Psychiatr Clin North Am; 2003 Sep; 26(3):563-80. PubMed ID: 14563098
[TBL] [Abstract][Full Text] [Related]
20. Nonhormone therapies for vasomotor symptom management.
Iyer TK; Fiffick AN; Batur P
Cleve Clin J Med; 2024 Apr; 91(4):237-244. PubMed ID: 38561208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
